March 2021

To serve humanity, irrespective of caste, creed and religion, through best-in-class healthcare services at fair value, continuously improving efficiencies to sustain holistic development of the Organisation, growth across geographies and subsidising the health care for the economically weaker sections of the society. MARWARI HOSPITALS (A unit of Shree Marwari Databya Aushadhalaya) Sati Jaimati Road, Athgaon, Guwahati -781008 Invites application for the post of Pharmacist.

The ECHS Central Organisation is located at Delhi and functions under the Chief of Staff Committee (COSC) through AG and DGDC&W in Army HQ. The Central organisation is headed by Managing Director, ECHS, a serving Major General. There are 28 Regional Centres ECHS and 426 ECHS Polyclinics. ECHS is also an attached office of Dept of Ex-Servivemen Welfare (DoESW), Ministry of Defence (MoD) as are Directorate General Resettlement(DGR) and Kendriya Sainik Board (KSB). \

Cellexa Lifesciences is a Pharmaceutical startup, with a focus on Dermatology. We are a Mumbai based organization & our registered office is in Thane, Mumbai. Though we are a startup, the founders are all experienced Pharmaceutical professionals with a collective experience of over 7 decades in various fields of the Pharmaceutical Industry including; Marketing, Sales, Sourcing, R&D, Business development & Market research.

Post : Medical Representative

No of Posts : 08

TIFR is a National Centre of the Government of India, under the umbrella of the Department of Atomic Energy, as well as a deemed University awarding degrees for master's and doctoral programs. The Institute was founded in 1945 with support from the Sir Dorabji Tata Trust under the vision of Dr. Homi Bhabha. At TIFR, we carry out basic research in physics, chemistry, biology, mathematics, computer science and science education. Our main campus is located in Mumbai, with centres at Pune, Bengaluru and Hyderabad.

New research at Washington University School of Medicine in St. Louis indicates that three new, fast-spreading variants of the virus that cause COVID-19 can evade antibodies that work against the original form of the virus that sparked the pandemic. With few exceptions, whether such antibodies were produced in response to vaccination or natural infection, or were purified antibodies intended for use as drugs, the researchers found more antibody is needed to neutralize the new variants.

New treatments for Alzheimer’s disease are desperately needed, but numerous clinical trials of investigational drugs have failed to generate promising options. Now a team at Massachusetts General Hospital (MGH) and Harvard Medical School (HMS) has developed an artificial intelligence based method to screen currently available medications as possible treatments for Alzheimer’s disease. The method could represent a rapid and inexpensive way to repurpose existing therapies into new treatments for this progressive, debilitating neurodegenerative condition.

In 1993, scientists discovered that a single mutated gene, HTT, caused Huntington's disease, raising high hopes for a quick cure. Yet today, there's still no approved treatment.

About Author
Mohd Riyaz Beg
Institute of Chemical Technology, Mumbai
Email: mohdriyazbeg@gmail.com

Translational Health Science and Technology Institute (THSTI) is an autonomous Institute of the Department of Biotechnology (DBT), Ministry of Science and Technology, Govt. of India. The institute is an integral part of the interdisciplinary NCR Biotech Science Cluster (NCR BSC) located at Faridabad, and is designed with the mission to conduct innovative translational research to translate concepts into products to improve human health.